ID: ALA540097

Max Phase: Preclinical

Molecular Formula: C14H23Cl2N3O

Molecular Weight: 247.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](N)C1CCC(C(=O)Nc2ccncc2)CC1.Cl.Cl

Standard InChI:  InChI=1S/C14H21N3O.2ClH/c1-10(15)11-2-4-12(5-3-11)14(18)17-13-6-8-16-9-7-13;;/h6-12H,2-5,15H2,1H3,(H,16,17,18);2*1H/t10-,11?,12?;;/m0../s1

Standard InChI Key:  IDDDVXIUIXWAGJ-JKTOABMASA-N

Associated Targets(Human)

Rho-associated protein kinase 137 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

NG108-15 132 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 247.34Molecular Weight (Monoisotopic): 247.1685AlogP: 2.17#Rotatable Bonds: 3
Polar Surface Area: 68.01Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.44CX Basic pKa: 10.45CX LogP: 1.34CX LogD: -1.41
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.86Np Likeness Score: -1.25

References

1. Gingras K, Avedissian H, Thouin E, Boulanger V, Essagian C, McKerracher L, Lubell WD..  (2004)  Synthesis and evaluation of 4-(1-aminoalkyl)-N-(4-pyridyl)cyclohexanecarboxamides as Rho kinase inhibitors and neurite outgrowth promoters.,  14  (19): [PMID:15341954] [10.1016/j.bmcl.2004.07.025]

Source